Freed is an AI scribe that listens, transcribes, and writes SOAP notes in real time—saving clinicians hours on documentation. It generates comprehensive SOAP notes quickly, enhancing work efficiency. Freed's platform listens, transcribes, and generates comprehensive clinical notes during patient visits. Clinicians initiate the process by starting the app at the beginning of a visit; the AI captures the conversation and produces structured notes within 60 seconds after concluding the visit. These notes can be reviewed and seamlessly integrated into electronic health records (EHRs).
OpenEvidence
Series A in 2025
Information overload is an extreme challenge in medicine - the amount of medical research published annually is doubling every 5 years.
Such a rate of change makes it nearly impossible for the world’s physicians, medical researchers, and healthcare professionals to monitor and understand all the latest research literature and clinical evidence relevant to their work.
OpenEvidence tames this medical information firehose. We provide an artificial intelligence system to aggregate, synthesize, and visualize clinically relevant evidence in understandable, accessible formats that can be used to make more evidenced-based decisions, ease the cognitive load on clinicians, and improve patient outcomes.
OpenEvidence is trusted by over 7,000 care centers across the United States and used in over 170 countries worldwide.
Avelios Medical
Series A in 2025
Avelios Medical operates a modular clinic platform designed to enhance patient care by digitizing and optimizing clinic processes. The platform provides comprehensive support for healthcare staff, streamlining their daily tasks and fostering the integration of advanced technologies. By incorporating innovations such as artificial intelligence, big data, telemedicine, patient applications, and wearables, Avelios Medical aims to fundamentally transform healthcare delivery and research. This approach not only automates various operational processes but also enhances the overall efficiency and effectiveness of hospitals and clinics.
Founded in New York in 2021 by Arun Ranganathan, Roon is an online platform designed to support individuals navigating complex health conditions. It facilitates connections among patients dealing with various diseases, allowing them to share experiences and build supportive communities.
XAI is a technology company specializing in artificial intelligence. It creates and deploys AI solutions, primarily using machine learning, to enhance data analysis and decision-making processes. XAI caters to the finance, healthcare, and logistics sectors, aiming to improve accuracy and efficiency in these industries.
Orasis Pharmaceuticals
Series D in 2024
Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.
Maven Clinic
Series F in 2024
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
GondolaBio
Venture Round in 2024
GondolaBio is a biopharmaceutical company dedicated to researching, developing, and manufacturing pharmaceutical products. Its primary focus is on creating therapeutics for patients with genetic diseases, addressing high unmet medical needs across various therapeutic areas and stages of development. The company leverages biological research to drive its mission, aiming to enable the healthcare industry to effectively treat and manage rare genetic conditions.
Formation Bio
Series D in 2024
Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.
Anterior is a healthcare technology company that uses AI to streamline administrative tasks in the U.S. healthcare system. Its platform, Florence, assists nurses and doctors in efficiently gathering medical documentation required by insurance companies, aiming to reduce denial rates and expedite patient access to essential treatments.
XAI is a technology company specializing in artificial intelligence. It creates and deploys AI solutions, primarily using machine learning, to enhance data analysis and decision-making processes. XAI caters to the finance, healthcare, and logistics sectors, aiming to improve accuracy and efficiency in these industries.
Summer Health
Series A in 2024
Summer Health facilitates convenient access to high-quality healthcare professionals via text messaging. It provides expert advice and reliable answers to users' health concerns.
Grow Therapy
Series C in 2024
Grow Therapy is a mental health technology company focused on enhancing access to quality mental healthcare. It offers therapists and prescribers a comprehensive suite of business tools and services, along with a peer community and a steady stream of matched patient referrals. This support enables practitioners to establish and expand successful in-person and virtual private practices tailored to the needs of their communities. By connecting patients with a diverse range of providers who accept their insurance, Grow Therapy facilitates improved access to mental health services across the United States. The company has built a network of thousands of providers and collaborates with major insurers, ensuring that more individuals receive the care they require.
Clinikally
Seed Round in 2023
Clinikally is India’s first integrated Telemedicine & E-Pharmacy platform specializing in Dermatology. It connects users with expert dermatologists within 30 minutes, providing personalized treatment plans and delivering Rx-grade products directly to their doorstep.
Anterior
Seed Round in 2023
Anterior is a healthcare technology company that uses AI to streamline administrative tasks in the U.S. healthcare system. Its platform, Florence, assists nurses and doctors in efficiently gathering medical documentation required by insurance companies, aiming to reduce denial rates and expedite patient access to essential treatments.
Caresync.website
Series A in 2023
Our telemedicine platform aims to transform the way healthcare is accessed, offering patients the flexibility to connect with trusted healthcare providers anytime, anywhere. Through our intuitive interface and advanced video conferencing capabilities, we enable seamless communication and personalized care delivery.
Caresync.website
Series A in 2023
Our telemedicine platform aims to transform the way healthcare is accessed, offering patients the flexibility to connect with trusted healthcare providers anytime, anywhere. Through our intuitive interface and advanced video conferencing capabilities, we enable seamless communication and personalized care delivery.
Welcome to Nexus.Cloud, your dedicated partner in revolutionizing healthcare data management. We specialize in providing secure cloud solutions tailored for hospitals, insurance companies, and patients, ensuring seamless storage, protection, and accessibility of medical records. With our comprehensive services, we aim to streamline healthcare operations and enhance patient experiences.
Why Choose Nexus.Cloud?
Medical Data Security: At Nexus.Cloud, we understand the sensitivity of medical records. Our state-of-the-art security measures safeguard patient data, adhering to strict industry regulations and compliance standards.
Efficient Cloud Storage: Bid farewell to cumbersome paper-based systems. Our cloud solutions enable hospitals and insurance companies to digitize and efficiently store vast volumes of medical data, eliminating the need for physical storage and reducing administrative burden.
Patient-Centric Approach: Patients' well-being is at the heart of our services. With our user-friendly platforms, patients gain secure access to their medical records, empowering them to take charge of their health and make informed decisions.
Automated Appointment Reminders: We value patients' time and strive to enhance their healthcare journey. Through automated appointment reminders, we ensure patients never miss critical medical consultations, leading to improved care outcomes.
Scalable and Flexible Solutions: Whether you are a small clinic or a large hospital network, our cloud services are designed to scale with your needs. Enjoy the flexibility to customize solutions that align with your organization's unique requirements.
Maven Clinic
Series E in 2022
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
GigaMune
Seed Round in 2022
Founded in 2017 as a spin‑out from GigaGen, GigaMune is a biotechnology company focused on next‑generation T cell therapies. It combines deep insights into T cell responses to tumors with massively parallel T cell receptor discovery to identify novel therapeutic targets. The company also develops genome‑edited cancer cell therapies, offering technology that supports database‑scale sequence searches, high‑throughput screening of anti‑tumor payloads, and the use of engineered viruses for payload delivery. These tools enable the rapid development of effective treatments for various cancers.
Founded in New York in 2021 by Arun Ranganathan, Roon is an online platform designed to support individuals navigating complex health conditions. It facilitates connections among patients dealing with various diseases, allowing them to share experiences and build supportive communities.
WonderMind
Seed Round in 2022
Wondermind is a mental fitness ecosystem founded by Selena Gomez, Mandy Teefey, and Daniella Pierson, dedicated to democratizing and destigmatizing mental health. The company offers a platform that provides accessible and affordable mental health care through daily engaging content, consumer packaged goods, and storytelling. Users receive customized peer-to-peer support and resources designed to enhance their understanding of mental wellness. By focusing on practical and achievable methods for prioritizing mental fitness, Wondermind aims to empower individuals to improve their well-being and capitalize on their strengths.
Summer Health
Seed Round in 2022
Summer Health facilitates convenient access to high-quality healthcare professionals via text messaging. It provides expert advice and reliable answers to users' health concerns.
Medallion
Series C in 2022
Medallion is a San Francisco-based company founded in 2020 by Derek Lo, specializing in a network management platform tailored for the healthcare industry. The company offers an all-in-one solution for licensing, credentialing, and payer enrollment, aimed at simplifying the often cumbersome processes associated with healthcare paperwork. Its platform provides features such as primary source verification, continuing medical education tracking, and document management, enabling healthcare providers and telemedicine companies to minimize time spent on administrative tasks and focus more on patient care.
MyOme develops a genetic testing technology that provides comprehensive health insights through whole genome sequencing. Its platform offers detailed reports on disease risk and medication response, accompanied by independent physician reviews and genetic counseling. The company ensures ongoing updates using advanced technologies, empowering individuals to make informed health decisions while maintaining data privacy and security.
Caresync.website
Pre Seed Round in 2022
Our telemedicine platform aims to transform the way healthcare is accessed, offering patients the flexibility to connect with trusted healthcare providers anytime, anywhere. Through our intuitive interface and advanced video conferencing capabilities, we enable seamless communication and personalized care delivery.
Us2.ai specializes in developing artificial intelligence-driven software and digital tools for echocardiography. Based in Singapore, it offers online solutions to simplify access to echo analysis results and heart ultrasound.
Health Hero
Seed Round in 2022
Health Hero, Inc. is a wellness technology company that specializes in developing a custom wellness platform aimed at enhancing employee well-being across various industries globally. Founded in 2014 and headquartered in Tampa, Florida, the company offers a range of wellness options, including health risk assessments, cultural assessments, and biometric screenings, which can be accessed through mobile devices and computers. Health Hero's platform integrates gamification elements to engage employees by allowing them to earn points, badges, and rewards for completing tasks and reaching milestones. With a user reach exceeding five million and support for over 14,000 companies and communities, Health Hero effectively stores more than five billion health data points, positioning itself as a leader in the well-being sector.
Hebin Intelligence
Seed Round in 2022
Hebin Intelligence is an AI ultrasonic medical robot company providing remote ultrasound autonomous ultrasound diagnosis robots.
Kenko Health
Series A in 2022
Kenko Health is a health management organization that focuses on providing comprehensive healthcare financing services. The company offers affordable plans designed to cover a wide range of medical expenses, including medications, doctor visits, lab tests, mental health services, dental care, and outpatient hospital bills. By emphasizing low monthly fees, Kenko Health aims to make healthcare more accessible and manageable for its customers, ensuring they receive the necessary medical coverage and prepaid benefits for their health needs.
Clipboard Health
Series C in 2022
Clipboard Health is a healthcare staffing marketplace established in 2016 and headquartered in San Francisco, California. The company connects nursing professionals with medical facilities, allowing nurses to search and apply for jobs based on their qualifications and preferences with a single click. Its platform features a comprehensive database of nursing and allied health job opportunities across the nation, streamlining the recruitment process for both healthcare providers and staff. By facilitating tailored job placements, Clipboard Health aims to ensure that patients receive appropriate care from qualified nursing personnel when needed.
Athelas
Venture Round in 2022
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.
Transcenta Holding
Post in 2021
Transcenta Holding is a clinical-stage biopharmaceutical company that offers fully integrated capabilities in antibody discovery, research and development, manufacturing, and business development. The company concentrates on developing innovative antibody-based therapeutics for oncology and selected non-oncology indications, including bone and kidney disorders, with a pipeline that includes Osemitamab (TST001), TST002, TST003, TST006, MSB2311, MSB0254, TST808, and other candidates. Headquartered with multiple sites in China—Suzhou, Shanghai, Hangzhou, and Beijing—and with research and development and operations in the United States at Waltham and Princeton, Transcenta operates as a global biotherapeutics business. Founded in 2019, the company aims to advance therapeutic antibodies through discovery, development, and manufacturing to address unmet patient needs. Its business scope encompasses clinical research and trial services alongside its development programs, positioning it to accelerate pipeline progress and collaborate on global opportunities.
Medallion
Series B in 2021
Medallion is a San Francisco-based company founded in 2020 by Derek Lo, specializing in a network management platform tailored for the healthcare industry. The company offers an all-in-one solution for licensing, credentialing, and payer enrollment, aimed at simplifying the often cumbersome processes associated with healthcare paperwork. Its platform provides features such as primary source verification, continuing medical education tracking, and document management, enabling healthcare providers and telemedicine companies to minimize time spent on administrative tasks and focus more on patient care.
Cambridge Epigenetix
Series D in 2021
Cambridge Epigenetix Limited is a bioscience company based in Babraham, United Kingdom, specializing in epigenetic tools that aim to transform medical diagnostics. Founded in 2012 as a spin-out from the University of Cambridge, the company is pioneering the clinical applications of epigenetics, particularly through its innovative TrueMethyl technology. This includes oxidative bisulfite sequencing, which allows for the precise sequencing of hydroxymethyl cytosine and methylcytosine at single-base resolution. Cambridge Epigenetix offers a range of products, such as TrueMethyl 6 and TrueMethyl 24 kits, designed for the quantitative measurement and analysis of these critical epigenetic markers. The company’s research highlights the significance of 5-hydroxymethylcytosine as a biomarker for various diseases, including colorectal cancer, and aims to simplify diagnostic processes to a simple blood draw. The firm collaborates with third-party vendors and sells its products directly to business customers both in the UK and internationally.
Formation Bio
Series C in 2021
Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.
GenEdit Inc., established in 2016 and headquartered in Berkeley, California, specializes in developing innovative genome editing tools. The company's core technology is CRISPR/Cas9, which enables precise therapeutic gene editing. GenEdit has further advanced this field by creating the NanoGalaxy™ platform, a proprietary non-viral delivery system that efficiently transports CRISPR/Cas9 to target tissues, overcoming previous delivery challenges. This platform systematically screens a library of nanoparticles to ensure safer and more effective delivery, making therapeutic gene editing easier, faster, and more accurate than traditional methods. GenEdit's ultimate goal is to facilitate the cure of previously incurable genetic diseases by providing physicians with powerful tools for gene therapy.
Sirka is Indonesia's first metabolic clinic, specializing in healthcare innovation with a focus on obesity and metabolic health. The company adopts a tech-enabled, holistic approach to managing weight and chronic diseases, addressing the root causes of these issues. Sirka offers personalized programs that encompass weight management, digestive health, diabetes care, and chronic disease management. Through expert medical care and customized nutrition plans, the clinic tailors its services to meet individual needs while providing continuous monitoring to ensure effective support for long-term success. Additionally, Sirka's application connects users with dietitians for meal plan recommendations, facilitating goal setting related to diet and health conditions. This comprehensive approach empowers Indonesians to lead healthier lives with improved weight management and better control over chronic diseases.
Maven Clinic
Series D in 2021
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
Beijing Yuan Xin
Series F in 2021
Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.
Gong.io, Inc. develops and markets a sales conversation intelligence platform designed to enhance the performance of remote sales teams. The platform captures, analyzes, and delivers insights from customer interactions, providing valuable deal and people intelligence. Its Revenue Intelligence solution supports various applications, including sales improvement, training, onboarding, strategy, engagement, enablement, and conversation analysis. The cloud-based platform employs artificial intelligence to automatically record and transcribe sales conversations, integrating results from audio sources and web-conferencing tools with customer relationship management systems. This functionality enables organizations to save time, improve win rates, enhance strategic decision-making, and ultimately drive revenue growth. Founded in 2015, Gong.io is headquartered in San Francisco, California, with an additional office in Ramat Gan, Israel.
Noom, Inc. is a New York-based company that specializes in mobile health coaching through a psychology-based digital health platform. Founded in 2008, Noom develops a mobile application that combines evidence-based curricula, personalized coaching, and data-driven insights to help users achieve their health and wellness goals, including weight management and chronic disease prevention. The platform offers scalable tools for exercise and nutrition coaching, utilizing artificial intelligence to facilitate behavioral change. Recognized for its innovative approach, Noom has received multiple grants from the National Institutes of Health and was the first mobile application certified by the Centers for Disease Control as a diabetes prevention program. The company also caters to business enterprises, supporting organizations in promoting employee health. With additional offices in Seoul and Tokyo, Noom continues to expand its global reach and impact on personal health management.
DeepScribe
Seed Round in 2021
DeepScribe develops an AI-powered platform that automates medical note-taking for clinicians. Its solution captures and transcribes clinical conversations in real-time, extracts relevant information, and integrates notes into electronic health records (EHR). DeepScribe enables healthcare providers to focus on patient care while reducing documentation burden.
Ethos Life
Series D in 2021
Ethos Life is an insurance company based in San Francisco, California, that specializes in providing modern and ethical life insurance products, primarily term life insurance. Founded in 2016, Ethos aims to make life insurance affordable, accessible, and instant, addressing a significant market valued at $650 billion. The company employs innovative software to enhance the customer experience and utilizes technology to tailor coverage to individual needs. Ethos policies are issued and guaranteed by Legal & General America, a well-established life insurance provider. The company emphasizes a human approach in its services, striving to protect families through personalized insurance solutions.
Vim Inc., established in 2015 and headquartered in San Francisco, specializes in a healthcare platform that facilitates online services for patients and healthcare providers. The company's core offerings include online appointment scheduling solutions and referral coordination services, aiming to streamline care delivery between patients and medical professionals. Vim connects health plans, patients, and providers across various sizes and systems, with the mission of enhancing affordable, high-quality healthcare through seamless data connectivity within clinical operations at the point of patient care.
Pendulum Therapeutics
Series C in 2021
Pendulum Therapeutics is a biotechnology company specializing in microbiome-targeted therapies. Founded in 2013 by experts in microbiology, biochemistry, computational science, and clinical research, the company develops evidence-based medical probiotics to manage chronic illnesses, with a focus on type 2 diabetes. Its flagship product, Pendulum Glucose Control, has demonstrated efficacy in lowering blood sugar spikes and reducing A1C levels in clinical trials.
Miaoshou Doctor
Series E in 2021
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.
Expectful
Seed Round in 2021
Expectful is a digital health and wellness platform focused on supporting women throughout their reproductive journey, including preconception, pregnancy, and postpartum stages. The platform offers a range of resources such as guided meditations, mindfulness exercises, and expert advice tailored to the unique needs of expectant and new mothers. By providing a non-pharmacologic and accessible approach to mental health, Expectful aims to reduce prenatal and postpartum stress, enhancing the overall well-being of both mothers and infants. The app is designed to make meditation easy and effective, helping users navigate the physical, mental, and emotional challenges associated with motherhood.
Novotech
Secondary Market in 2021
Novotech is Australia’s largest independent CRO. The Australian Head Office is in Sydney, with regional offices in Melbourne and Brisbane - providing easy access to the most important population centers in Australia. Supported by regional staff across the country and in New Zealand, our coverage of the Australia/New Zealand region is comprehensive. With Asian services launched in 2007, Novotech’s operations provide access to the most dynamic and fast growing clinical research hubs in the region.
HeyBro
Venture Round in 2021
HeyBro only provides effective health products for men. It is China's first Internet-based pharmaceutical brand focusing on men's health. In cooperation with Fudan Sinopharm Biopharmaceutical Joint Research Center, it has established the first men's health laboratory in China. Skin care and other fields help men get rid of health problems, cope with life easily, continue to improve, and show the hard-core charm of contemporary men.
Founded in 2006, 23andMe is a biotechnology company specializing in direct-to-consumer genetic testing. It offers DNA analysis services through home-based saliva collection kits, providing insights into ancestry, traits, and health risks.
Transcenta Holding
Series C in 2020
Transcenta Holding is a clinical-stage biopharmaceutical company that offers fully integrated capabilities in antibody discovery, research and development, manufacturing, and business development. The company concentrates on developing innovative antibody-based therapeutics for oncology and selected non-oncology indications, including bone and kidney disorders, with a pipeline that includes Osemitamab (TST001), TST002, TST003, TST006, MSB2311, MSB0254, TST808, and other candidates. Headquartered with multiple sites in China—Suzhou, Shanghai, Hangzhou, and Beijing—and with research and development and operations in the United States at Waltham and Princeton, Transcenta operates as a global biotherapeutics business. Founded in 2019, the company aims to advance therapeutic antibodies through discovery, development, and manufacturing to address unmet patient needs. Its business scope encompasses clinical research and trial services alongside its development programs, positioning it to accelerate pipeline progress and collaborate on global opportunities.
Twin Health
Series B in 2020
Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.
Whisper.ai, Inc. is a company that specializes in the development and manufacturing of AI-enabled hearing aids aimed at individuals with hearing loss. Founded in 2017 and located in San Francisco, California, Whisper offers a modern hearing system that includes the Whisper Brain, which utilizes advanced AI algorithms to process and enhance sound in real time. This system is complemented by earpieces that deliver the optimized sound directly to the user. Additionally, the Whisper app provides regular software updates, allowing for continuous improvements and novel features. The technology is designed to adapt to various environments, enhancing the hearing experience for users.
Orasis Pharmaceuticals
Series C in 2020
Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.
Biofourmis
Series C in 2020
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.
Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.
Gong.io, Inc. develops and markets a sales conversation intelligence platform designed to enhance the performance of remote sales teams. The platform captures, analyzes, and delivers insights from customer interactions, providing valuable deal and people intelligence. Its Revenue Intelligence solution supports various applications, including sales improvement, training, onboarding, strategy, engagement, enablement, and conversation analysis. The cloud-based platform employs artificial intelligence to automatically record and transcribe sales conversations, integrating results from audio sources and web-conferencing tools with customer relationship management systems. This functionality enables organizations to save time, improve win rates, enhance strategic decision-making, and ultimately drive revenue growth. Founded in 2015, Gong.io is headquartered in San Francisco, California, with an additional office in Ramat Gan, Israel.
Twin Health
Series A in 2020
Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.
Healthlane
Convertible Note in 2020
Healthlane operates an online platform that connects users with healthcare services. Its application enables users to track appointments at medical facilities, compile health data in one place, and access unlimited health services including virtual consultations with certified doctors.
Limbix is a company dedicated to developing prescription digital therapeutics for adolescent mental health. Their flagship product, SparkRx, is an evidence-based, clinically validated tool designed to treat depression and anxiety in teenagers. Limbix combines clinical expertise with technological innovation to deliver effective mental health treatments.
Plum
Pre Seed Round in 2020
Plum specializes in providing group health insurance with transparent pricing, no hidden fees or out-of-pocket expenses. Their platform offers customizable plans, including doctor consultations, health check-ups, mental wellness support, dental care, and COVID-19 coverage.
MedGenome
Series D in 2020
MedGenome develops sequencing-based diagnostics and a research platform that combines genomics technologies, bioinformatics, computing, and big data analytics to understand the genetic basis of cancer, metabolic disorders, eye disorders, and other rare diseases in diverse populations. The platform enables high-end genetic diagnostic tests across immuno-oncology, infectious diseases, reproductive health, and rare diseases, and serves patients, pharmaceutical companies, and research institutions worldwide by delivering deep insights into diseases at the genetic and molecular level to advance global health.
BUFFX is a food production company based in Hangzhou, Zhejiang, founded in 2020. The company specializes in the manufacture and sale of supplementary food products, focusing on innovative candy options that provide essential nutrients. BUFFX's product line includes blueberry gummies, candies, and fruit juice capsules, designed to cater to consumers seeking both nutritional benefits and tasty treats. By combining functionality with flavor, BUFFX aims to meet the growing demand for functional foods in China.
Maven Clinic
Series C in 2020
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
Gong.io, Inc. develops and markets a sales conversation intelligence platform designed to enhance the performance of remote sales teams. The platform captures, analyzes, and delivers insights from customer interactions, providing valuable deal and people intelligence. Its Revenue Intelligence solution supports various applications, including sales improvement, training, onboarding, strategy, engagement, enablement, and conversation analysis. The cloud-based platform employs artificial intelligence to automatically record and transcribe sales conversations, integrating results from audio sources and web-conferencing tools with customer relationship management systems. This functionality enables organizations to save time, improve win rates, enhance strategic decision-making, and ultimately drive revenue growth. Founded in 2015, Gong.io is headquartered in San Francisco, California, with an additional office in Ramat Gan, Israel.
Migraine.AI
Seed Round in 2019
Migraine.AI is an innovative application designed to manage migraine attacks personally. It predicts migraine occurrences and optimizes medication windows using passive health monitoring tools tailored specifically for women.
Ethos Life
Series C in 2019
Ethos Life is an insurance company based in San Francisco, California, that specializes in providing modern and ethical life insurance products, primarily term life insurance. Founded in 2016, Ethos aims to make life insurance affordable, accessible, and instant, addressing a significant market valued at $650 billion. The company employs innovative software to enhance the customer experience and utilizes technology to tailor coverage to individual needs. Ethos policies are issued and guaranteed by Legal & General America, a well-established life insurance provider. The company emphasizes a human approach in its services, striving to protect families through personalized insurance solutions.
1mg is an Indian digital healthcare platform, launched in 2015, that operates from Gurgaon, Haryana. It aims to make healthcare more accessible, understandable, and affordable. The platform enables users to find detailed information about prescribed medicines, buy them, and search for drugs based on ailments, classes, companies, and brands. Additionally, 1mg offers a doctor platform to help users find suitable healthcare professionals and a diagnostics service for transparent and cost-effective lab tests. The company empowers consumers and caregivers to choose the most appropriate healthcare services at competitive prices.
Pendulum Therapeutics
Series B in 2019
Pendulum Therapeutics is a biotechnology company specializing in microbiome-targeted therapies. Founded in 2013 by experts in microbiology, biochemistry, computational science, and clinical research, the company develops evidence-based medical probiotics to manage chronic illnesses, with a focus on type 2 diabetes. Its flagship product, Pendulum Glucose Control, has demonstrated efficacy in lowering blood sugar spikes and reducing A1C levels in clinical trials.
Noom, Inc. is a New York-based company that specializes in mobile health coaching through a psychology-based digital health platform. Founded in 2008, Noom develops a mobile application that combines evidence-based curricula, personalized coaching, and data-driven insights to help users achieve their health and wellness goals, including weight management and chronic disease prevention. The platform offers scalable tools for exercise and nutrition coaching, utilizing artificial intelligence to facilitate behavioral change. Recognized for its innovative approach, Noom has received multiple grants from the National Institutes of Health and was the first mobile application certified by the Centers for Disease Control as a diabetes prevention program. The company also caters to business enterprises, supporting organizations in promoting employee health. With additional offices in Seoul and Tokyo, Noom continues to expand its global reach and impact on personal health management.
Health Catalyst
Series F in 2019
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
Health Catalyst
Debt Financing in 2019
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.
Phrase Health
Pre Seed Round in 2019
Founded in 2018, Phrase Health specializes in healthcare software solutions. Based in Philadelphia, Pennsylvania, the company helps hospitals monitor and analyze information provided to doctors and nurses at the point of care, enabling data-driven process improvements.
Genedit
Seed Round in 2018
GenEdit Inc., established in 2016 and headquartered in Berkeley, California, specializes in developing innovative genome editing tools. The company's core technology is CRISPR/Cas9, which enables precise therapeutic gene editing. GenEdit has further advanced this field by creating the NanoGalaxy™ platform, a proprietary non-viral delivery system that efficiently transports CRISPR/Cas9 to target tissues, overcoming previous delivery challenges. This platform systematically screens a library of nanoparticles to ensure safer and more effective delivery, making therapeutic gene editing easier, faster, and more accurate than traditional methods. GenEdit's ultimate goal is to facilitate the cure of previously incurable genetic diseases by providing physicians with powerful tools for gene therapy.
Bubble Goods
Pre Seed Round in 2018
Bubble Goods is an online marketplace that enables consumers to discover and shop for healthy foods from independent brands across the United States. Founded in 2018 and based in New York, it focuses on mid-tier brands and vets each product with nutritionists and experts to ensure health-focused quality. The platform features a curated selection of fresh and clean foods, including snacks, beverages, pantry staples, and functional products, with offerings produced by both in-house teams and independent producers. Bubble Goods aims to simplify access to vetted health products by providing a single shop that aligns with individual dietary and functional needs.
NextCODE Health
Series C in 2018
WuXi NextCODE operates as a clinical diagnostics company specializing in sequence-based genomics. The firm provides a platform that assists physicians in obtaining critical clinical insights, enabling rapid and accurate diagnoses for patients. Its services include genome interpretation, data analysis, and data mining, along with security and data protection measures. The company also offers custom integration services and both clinical-grade and non-clinical-grade sequencing. With technology developed over 16 years at deCODE genetics, WuXi NextCODE aims to facilitate the integration of genomic data into patient care and diagnosis. Based in Cambridge, Massachusetts, the company was acquired by WuXi AppTec in 2015 and has since focused on addressing the challenges of genome interpretation and big data in healthcare.
Ethos Life
Series B in 2018
Ethos Life is an insurance company based in San Francisco, California, that specializes in providing modern and ethical life insurance products, primarily term life insurance. Founded in 2016, Ethos aims to make life insurance affordable, accessible, and instant, addressing a significant market valued at $650 billion. The company employs innovative software to enhance the customer experience and utilizes technology to tailor coverage to individual needs. Ethos policies are issued and guaranteed by Legal & General America, a well-established life insurance provider. The company emphasizes a human approach in its services, striving to protect families through personalized insurance solutions.
Formation Bio
Funding Round in 2018
Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.
Maven Clinic
Series B in 2018
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
Cambridge Epigenetix
Series C in 2018
Cambridge Epigenetix Limited is a bioscience company based in Babraham, United Kingdom, specializing in epigenetic tools that aim to transform medical diagnostics. Founded in 2012 as a spin-out from the University of Cambridge, the company is pioneering the clinical applications of epigenetics, particularly through its innovative TrueMethyl technology. This includes oxidative bisulfite sequencing, which allows for the precise sequencing of hydroxymethyl cytosine and methylcytosine at single-base resolution. Cambridge Epigenetix offers a range of products, such as TrueMethyl 6 and TrueMethyl 24 kits, designed for the quantitative measurement and analysis of these critical epigenetic markers. The company’s research highlights the significance of 5-hydroxymethylcytosine as a biomarker for various diseases, including colorectal cancer, and aims to simplify diagnostic processes to a simple blood draw. The firm collaborates with third-party vendors and sells its products directly to business customers both in the UK and internationally.
Ethos Life
Series A in 2018
Ethos Life is an insurance company based in San Francisco, California, that specializes in providing modern and ethical life insurance products, primarily term life insurance. Founded in 2016, Ethos aims to make life insurance affordable, accessible, and instant, addressing a significant market valued at $650 billion. The company employs innovative software to enhance the customer experience and utilizes technology to tailor coverage to individual needs. Ethos policies are issued and guaranteed by Legal & General America, a well-established life insurance provider. The company emphasizes a human approach in its services, striving to protect families through personalized insurance solutions.
Orasis Pharmaceuticals
Series B in 2018
Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.
Decent Inc. is a health insurance provider based in Mill Valley, California, that focuses on offering affordable medical insurance plans tailored for self-employed professionals. Founded in 2018, the company aims to improve healthcare access by aligning incentives to enhance health outcomes and reduce costs. One of its key offerings is the Trailblazer Plan, a comprehensive health plan designed specifically for freelancers. By prioritizing the needs of its members, Decent seeks to create a more effective and personalized healthcare experience.
EOC Pharma Group
Series B in 2017
EOC Pharma Group is a biopharmaceutical company based in Shanghai, China, founded in 2015. It specializes in the development, manufacturing, and commercialization of innovative oncology products. EOC employs a licensing model to enhance its product pipeline by incorporating molecules from global biopharmaceutical partners into its robust local infrastructure, which includes manufacturing, clinical development, regulatory filing, and commercialization. The company has a diverse pipeline featuring seven novel products, several of which are positioned as potentially first- and best-in-class. EOC has achieved regulatory milestones with four Class I innovative drug approvals and has initiated clinical studies for its leading products. The company operates an 8,000 square meter cGMP manufacturing facility in Taizhou and maintains offices in key locations, including Shanghai, Beijing, Hong Kong, and Los Angeles. With a team of experienced professionals, EOC aims to establish itself as a leader in oncology innovation in China through strategic partnerships and a comprehensive integrated platform.
Provider of on demand drug delivery platform intended to create a better experience for patients at a lower price. Nimble partners with pharmacies nationwide to provide prescription delivery, as well as a mobile app for patients to manage and review prescriptions/orders from their phone.
VoxelCloud
Series A in 2017
VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.
Formation Bio
Funding Round in 2017
Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.
Infervision
Series B in 2017
Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.
NextCODE Health
Series B in 2017
WuXi NextCODE operates as a clinical diagnostics company specializing in sequence-based genomics. The firm provides a platform that assists physicians in obtaining critical clinical insights, enabling rapid and accurate diagnoses for patients. Its services include genome interpretation, data analysis, and data mining, along with security and data protection measures. The company also offers custom integration services and both clinical-grade and non-clinical-grade sequencing. With technology developed over 16 years at deCODE genetics, WuXi NextCODE aims to facilitate the integration of genomic data into patient care and diagnosis. Based in Cambridge, Massachusetts, the company was acquired by WuXi AppTec in 2015 and has since focused on addressing the challenges of genome interpretation and big data in healthcare.
Founded in 2006, 23andMe is a biotechnology company specializing in direct-to-consumer genetic testing. It offers DNA analysis services through home-based saliva collection kits, providing insights into ancestry, traits, and health risks.
Athelas
Seed Round in 2017
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.
Vets First Choice
Venture Round in 2017
Vets First Choice provides veterinary practices with an online pharmacy and home delivery services. It partners with veterinarians to create insight into gaps in patient care and offer professionalized pro-active prescription management to drive client engagement and improve compliance.
The company was founded by Ben Shaw in 2010 and is based in Portland, Maine.
VoxelCloud
Series A in 2017
VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.
Comprehend Systems
Series C in 2017
Comprehend Systems, Inc. is a Redwood City, California-based company that specializes in cloud-based continuous quality solutions for clinical operations. Founded in 2010, the company offers a comprehensive suite of clinical intelligence applications designed to enhance the efficiency, safety, and quality of clinical trials. These applications cater to clinical operations executives, data managers, and medical monitors, providing tools for portfolio monitoring, continuous quality assessment, collaboration with contract research organizations (CROs), and risk and medical monitoring. Comprehend Systems aims to deliver actionable insights across studies, systems, sites, and vendors, thereby improving the overall clinical trial process. In 2019, it became a subsidiary of Saama Technologies, Inc.
Zipline designs, manufactures, and operates drones for delivering vital medical products such as vaccines, medicines, and blood. Based in Half Moon Bay, California, Zipline aims to provide instant access to these supplies worldwide.
Limbix is a company dedicated to developing prescription digital therapeutics for adolescent mental health. Their flagship product, SparkRx, is an evidence-based, clinically validated tool designed to treat depression and anxiety in teenagers. Limbix combines clinical expertise with technological innovation to deliver effective mental health treatments.
VoxelCloud
Seed Round in 2016
VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.
Ethos Life
Seed Round in 2016
Ethos Life is an insurance company based in San Francisco, California, that specializes in providing modern and ethical life insurance products, primarily term life insurance. Founded in 2016, Ethos aims to make life insurance affordable, accessible, and instant, addressing a significant market valued at $650 billion. The company employs innovative software to enhance the customer experience and utilizes technology to tailor coverage to individual needs. Ethos policies are issued and guaranteed by Legal & General America, a well-established life insurance provider. The company emphasizes a human approach in its services, striving to protect families through personalized insurance solutions.